← Leaderboards
Anushka Dongre
Cornell University
$683,706
Attributed
$683,706
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $227.9K · FY2022–24$250K$187.5K$125K$62.5K$0
'22
'23
'24
Funding mix
By agency
NIH$683,706 · 1
By mechanism
K22$683,706 · 1
Top collaborators
No co-investigators on record.
Most similar at Cornell University
Same institution · by research overlap
- Richard A. Cerione$48,981,550
- Claudia Fischbach$14,671,182
- Deborah J Fowell$18,762,986
- Holger Sondermann$3,312,708
- Mingming Wu$4,059,725
Others in their field
Other Rising Stars on “Immune Checkpoint Blockade”
- Yicheng Wang · Immunova Therapeutics, Llc$4,000,000
- Martin Pule · University College London$3,627,871
- Xu Chen · University Of California, San Francisco$3,581,285
- Dmitriy Zamarin · Sloan-Kettering Inst Can Research$3,530,063
- Yuwen Zhu · University Of Colorado Denver$3,496,594
- Seunghee Kim-Schulze · Icahn School Of Medicine At Mount Sinai$2,933,846
Research focus
Immune Checkpoint BlockadeImmune ClearanceBiological ProcessImmuneAnti-Ctla4Breast Cancer PatientCellsBreast CarcinomaCarcinomaExhibitsCytokineCell LineCytotoxic Cd8 T CellsDiagnostic BiomarkerDistantEndocrineCessation Of LifeEpithelial CellsEpithelial To Mesenchymal TransitionCharacteristicsChemokineExhaustExhaustionImmunoregulation
Grant awards (3)
Potentiating the Efficacy of Immune Checkpoint Blockade by Targeting Epithelial-Mesenchymal Transition (EMT)-induced Immunosuppression in Breast Carcinomas$227,902
K22 · FY2024 · CA · contact PI
Potentiating the Efficacy of Immune Checkpoint Blockade by Targeting Epithelial-Mesenchymal Transition (EMT)-induced Immunosuppression in Breast Carcinomas$227,902
K22 · FY2023 · CA · contact PI
Potentiating the Efficacy of Immune Checkpoint Blockade by Targeting Epithelial-Mesenchymal Transition (EMT)-induced Immunosuppression in Breast Carcinomas$227,902
K22 · FY2022 · CA · contact PI